Patient demographics and characteristics of each event
Index event | First recurrent event | Second recurrent event | Third recurrent event | |||||
CHD | ||||||||
Patients, n | 97 321 | 21 902 | 5601 | 1731 | ||||
Male, n (%) | 66 690 | (68.5) | ||||||
Age, years, median (Q1–Q3) | 65 | (56–77) | ||||||
Length of stay, days | ||||||||
Median (Q1–Q3) | 4 | (2–6) | 3 | (2–7) | 4 | (2–8) | 5 | (2–9) |
Time from last event to the current event, days | ||||||||
Median (Q1–Q3) | NA | 213 | (56–500) | 176 | (55–384) | 124 | (43–303) | |
Follow-up, months | ||||||||
Median (Q1–Q3) | 36 | (36–36) | 24 | (11–33) | 16 | (6–26) | 13 | (5–21) |
CBVD | ||||||||
Patients, n | 120 914 | 25 337 | 6644 | 2153 | ||||
Male, n (%) | 71 934 | (59.5) | ||||||
Age, years, median (Q1–Q3) | 71 | (61–80) | ||||||
Length of stay, days | ||||||||
Median (Q1–Q3) | 7 | (4–13) | 8 | (4–19) | 9 | (5–23) | 11 | (5–26) |
Time from last event to the current event, days | ||||||||
Median (Q1–Q3) | NA | 162 | (30–502) | 99 | (34–306) | 72 | (35–210) | |
Follow-up, months | ||||||||
Median (Q1–Q3) | 36 | (33–36) | 24 | (10–34) | 19 | (8–30) | 18 | (7–29) |
PAD | ||||||||
Patients, n | 14 794 | 5951 | 2463 | 1073 | ||||
Male, n (%) | 8534 | (57.7) | ||||||
Age, years, median (Q1–Q3) | 74 | (63–82) | ||||||
Length of stay, days | ||||||||
Median (Q1–Q3) | 8 | (3–16) | 7 | (3–15) | 7 | (3–15) | 7 | (3–15) |
Time from last event to the current event, days | ||||||||
Median (Q1–Q3) | NA | 112 | (37–366) | 112 | (39–297) | 115 | (42–287) | |
Follow-up, months | ||||||||
Median (Q1–Q3) | 36 | (14–36) | 22 | (8–33) | 17 | (6–27) | 13 | (5–23) |
CBVD, cerebrovascular disease; CHD, coronary heart disease; PAD, peripheral artery disease; Q, quartile.